Anti-centromere autoantibodies (ACA) are associated with pulmonary hypertension, and anti-nucleolar autoantibodies (ANA) are associated with progressive interstitial lung disease and pulmonary arterial hypertension (Betteridge et al. 2016). This evidence concerns the gene BTG3 and pulmonary arterial hypertension.